|
US3887699A
(en)
|
1969-03-24 |
1975-06-03 |
Seymour Yolles |
Biodegradable polymeric article for dispensing drugs
|
|
US3854480A
(en)
|
1969-04-01 |
1974-12-17 |
Alza Corp |
Drug-delivery system
|
|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4263428A
(en)
|
1978-03-24 |
1981-04-21 |
The Regents Of The University Of California |
Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
|
|
EP0052322B1
(de)
|
1980-11-10 |
1985-03-27 |
Gersonde, Klaus, Prof. Dr. |
Verfahren zur Herstellung von Lipid-Vesikeln durch Ultraschallbehandlung, Anwendung des Verfahrens und Vorrichtung zur Durchführung des Verfahrens
|
|
US4675189A
(en)
|
1980-11-18 |
1987-06-23 |
Syntex (U.S.A.) Inc. |
Microencapsulation of water soluble active polypeptides
|
|
PH19942A
(en)
|
1980-11-18 |
1986-08-14 |
Sintex Inc |
Microencapsulation of water soluble polypeptides
|
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
|
US4485045A
(en)
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
|
DE3374837D1
(en)
|
1982-02-17 |
1988-01-21 |
Ciba Geigy Ag |
Lipids in the aqueous phase
|
|
DE3218121A1
(de)
|
1982-05-14 |
1983-11-17 |
Leskovar, Peter, Dr.-Ing., 8000 München |
Arzneimittel zur tumorbehandlung
|
|
EP0102324A3
(de)
|
1982-07-29 |
1984-11-07 |
Ciba-Geigy Ag |
Lipide und Tenside in wässriger Phase
|
|
US4452775A
(en)
|
1982-12-03 |
1984-06-05 |
Syntex (U.S.A.) Inc. |
Cholesterol matrix delivery system for sustained release of macromolecules
|
|
US4544545A
(en)
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
|
HUT35524A
(en)
|
1983-08-02 |
1985-07-29 |
Hoechst Ag |
Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
|
|
ATE159858T1
(de)
|
1983-09-26 |
1997-11-15 |
Ehrenfeld Udo |
Mittel und erzeugnis für die diagnose und therapie von tumoren sowie zur behandlung von schwächen der zelligen und humoralen immunabwehr
|
|
DE3474511D1
(en)
|
1983-11-01 |
1988-11-17 |
Terumo Corp |
Pharmaceutical composition containing urokinase
|
|
DE3413608A1
(de)
|
1984-04-11 |
1985-10-24 |
Hoechst Ag, 6230 Frankfurt |
Implantierbare zubereitungen von regulatorischen peptiden mit gesteuerter freisetzung und verfahren zu ihrer herstellung
|
|
US5133974A
(en)
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
|
US6565841B1
(en)
|
1991-03-15 |
2003-05-20 |
Amgen, Inc. |
Pulmonary administration of granulocyte colony stimulating factor
|
|
IT1247472B
(it)
|
1991-05-31 |
1994-12-17 |
Fidia Spa |
Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
|
|
US5407686A
(en)
|
1991-11-27 |
1995-04-18 |
Sidmak Laboratories, Inc. |
Sustained release composition for oral administration of active ingredient
|
|
US5470582A
(en)
|
1992-02-07 |
1995-11-28 |
Syntex (U.S.A.) Inc. |
Controlled delivery of pharmaceuticals from preformed porous polymeric microparticles
|
|
JPH08503950A
(ja)
|
1992-12-02 |
1996-04-30 |
アルカーメス・コントロールド・セラピユーテイクス・インコーポレーテツド |
徐放性成長ホルモン含有マイクロスフェア
|
|
WO1995000645A2
(en)
|
1993-06-21 |
1995-01-05 |
Genentech, Inc. |
Process for producing relaxin
|
|
US6011007A
(en)
|
1993-09-17 |
2000-01-04 |
Novo Nordisk A/S |
Acylated insulin
|
|
SI0792290T1
(en)
|
1993-09-17 |
2001-12-31 |
Novo Nordisk As |
Acylated insulin
|
|
US6869930B1
(en)
|
1993-09-17 |
2005-03-22 |
Novo Nordisk A/S |
Acylated insulin
|
|
US6372716B1
(en)
|
1994-04-26 |
2002-04-16 |
Genetics Institute, Inc. |
Formulations for factor IX
|
|
ES2151079T3
(es)
|
1994-09-09 |
2000-12-16 |
Takeda Chemical Industries Ltd |
Preparacion de liberacion sostenida que contiene una sal metalica de un peptido.
|
|
WO1996029998A1
(en)
|
1995-03-28 |
1996-10-03 |
Fidia Advanced Biopolymers S.R.L. |
Nanospheres comprising a biocompatible polysaccharide
|
|
US6184201B1
(en)
*
|
1995-04-14 |
2001-02-06 |
Nps Allelix Corp. |
Intestinotrophic glucagon-like peptide-2 analogs
|
|
WO1996040072A2
(en)
|
1995-06-07 |
1996-12-19 |
Alkermes Controlled Therapeutics, Inc. |
Composition for sustained release of human growth hormone
|
|
US5811395A
(en)
|
1995-06-07 |
1998-09-22 |
Medical University Of South Carolina |
Relaxin analogs and derivatives methods and uses thereof
|
|
US5911997A
(en)
|
1995-06-07 |
1999-06-15 |
Connetics Corporation |
Relaxin-like factor and methods and uses thereof
|
|
ZA965368B
(en)
|
1995-07-14 |
1997-01-14 |
Novo Nordisk As |
A pharmaceutical formulation
|
|
US6685940B2
(en)
|
1995-07-27 |
2004-02-03 |
Genentech, Inc. |
Protein formulation
|
|
US5736152A
(en)
|
1995-10-27 |
1998-04-07 |
Atrix Laboratories, Inc. |
Non-polymeric sustained release delivery system
|
|
US5612051A
(en)
|
1995-11-17 |
1997-03-18 |
Yue; Samuel K. |
Method of treating involuntary muscle dysfunction with relaxin hormone
|
|
US5866538A
(en)
|
1996-06-20 |
1999-02-02 |
Novo Nordisk A/S |
Insulin preparations containing NaCl
|
|
US6268343B1
(en)
|
1996-08-30 |
2001-07-31 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
|
US6444641B1
(en)
|
1997-10-24 |
2002-09-03 |
Eli Lilly Company |
Fatty acid-acylated insulin analogs
|
|
ZA989744B
(en)
|
1997-10-31 |
2000-04-26 |
Lilly Co Eli |
Method for administering acylated insulin.
|
|
DE19822820A1
(de)
|
1998-05-20 |
1999-11-25 |
Biotechnolog Forschung Gmbh |
Pharmazeutisches Präparat zur Wundbehandlung
|
|
US6566329B1
(en)
|
1999-06-28 |
2003-05-20 |
Novo Nordisk A/S |
Freeze-dried preparation of human growth hormone
|
|
HUP0400442A2
(hu)
|
2001-05-21 |
2005-03-29 |
Nektar Therapeutics |
Kémiailag módosított inzulin pulmonáris beadása és eljárás az előállítására
|
|
JP4723244B2
(ja)
|
2002-07-19 |
2011-07-13 |
オメロス コーポレイション |
生分解性トリブロックコポリマー、その合成方法、ならびにそれから作製されるヒドロゲルおよび生体材料
|
|
US20050176108A1
(en)
|
2003-03-13 |
2005-08-11 |
Young-Min Kim |
Physiologically active polypeptide conjugate having prolonged in vivo half-life
|
|
MXPA05012314A
(es)
|
2003-05-12 |
2006-04-18 |
Affymax Inc |
Radical separador para peptido modificado con polietilenglicol.
|
|
US20060183667A1
(en)
|
2003-07-11 |
2006-08-17 |
Novo Nordisk A/S |
Stabilised insulin compositions
|
|
CA2539253A1
(en)
|
2003-09-19 |
2005-03-31 |
Novo Nordisk A/S |
Albumin-binding derivatives of therapeutic peptides
|
|
EP1576952A1
(en)
|
2004-03-18 |
2005-09-21 |
OctoPlus Technologies B.V. |
Hydrogel microspheres with improved release profile
|
|
WO2005118620A2
(en)
|
2004-05-27 |
2005-12-15 |
New York University |
Methods for preparing internally constraied peptides and peptidomimetics
|
|
WO2006066258A2
(en)
*
|
2004-12-17 |
2006-06-22 |
Neose Technologies, Inc. |
Lipoconjugation of peptides
|
|
TWI372629B
(en)
*
|
2005-03-18 |
2012-09-21 |
Novo Nordisk As |
Acylated glp-1 compounds
|
|
US20080305519A1
(en)
|
2006-02-23 |
2008-12-11 |
Qing Lin |
Biochemical method for specific protein labeling
|
|
BRPI0709603A2
(pt)
|
2006-03-16 |
2011-07-19 |
Scripps Research Inst |
expressão de proteìnas geneticamente programada contendo o aminoácido não natural fenilselenocisteìna
|
|
RU2008141280A
(ru)
|
2006-03-20 |
2010-04-27 |
Мерк энд Ко., Инк. (US) |
Агонисты рецептора нейромедина u и их применение
|
|
CN101432025B
(zh)
|
2006-03-21 |
2012-04-04 |
安米林药品公司 |
肽-肽酶抑制剂结合物及其使用方法
|
|
KR20090031368A
(ko)
|
2006-05-26 |
2009-03-25 |
아밀린 파마슈티칼스, 인크. |
울혈성 심부전 치료용 조성물 및 방법
|
|
JP5290177B2
(ja)
*
|
2006-08-31 |
2013-09-18 |
セントカー・インコーポレーテツド |
Ｇｌｐ−２ミメティボディ、ポリペプチド、組成物、方法および用途
|
|
US8518668B2
(en)
|
2006-09-27 |
2013-08-27 |
Novo Nordisk A/S |
Method for making maturated insulin polypeptides in a fungal cell
|
|
WO2008057298A2
(en)
|
2006-10-27 |
2008-05-15 |
Wei-Chiang Shen |
Lipidized interferon and uses thereof
|
|
JP4616237B2
(ja)
|
2006-11-07 |
2011-01-19 |
日本電信電話株式会社 |
シリコン化合物薄膜の形成方法
|
|
US7960506B2
(en)
|
2006-12-14 |
2011-06-14 |
Aileron Therapeutics, Inc. |
Bis-sulfhydryl macrocyclization systems
|
|
US7981998B2
(en)
|
2006-12-14 |
2011-07-19 |
Aileron Therapeutics, Inc. |
Bis-sulfhydryl macrocyclization systems
|
|
WO2008104000A2
(en)
|
2007-02-23 |
2008-08-28 |
Aileron Therapeutics, Inc. |
Triazole macrocycle systems
|
|
US8420598B2
(en)
*
|
2007-04-20 |
2013-04-16 |
B & L Delipharm Corp. |
Mono modified exendin with polyethylene glycol or its derivatives and uses thereof
|
|
JP2010530433A
(ja)
*
|
2007-06-20 |
2010-09-09 |
メルク・シャープ・エンド・ドーム・コーポレイション |
Ａｐｏａ−１ペプチド模倣体
|
|
EP2242503A4
(en)
|
2008-02-08 |
2012-04-25 |
Aileron Therapeutics Inc |
THERAPEUTIC PEPTIDOMIMETIC MACROCYCLES
|
|
WO2009126292A2
(en)
|
2008-04-08 |
2009-10-15 |
Aileron Therapeutics, Inc. |
Biologically active peptidomimetic macrocycles
|
|
US20110144303A1
(en)
|
2008-04-08 |
2011-06-16 |
Aileron Therapeutics, Inc. |
Biologically Active Peptidomimetic Macrocycles
|
|
BRPI0915282A2
(pt)
|
2008-06-17 |
2017-02-07 |
Univ Indiana Res & Tech Corp |
agonistas mistos baseados no gip para o tratamento de distúrbios metabólicos e obesidade
|
|
EP2334317B1
(en)
|
2008-09-16 |
2017-06-14 |
The Research Foundation Of State University Of New York |
Stapled peptides and method of synthesis
|
|
US20120178700A1
(en)
|
2008-09-22 |
2012-07-12 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
JP2012503025A
(ja)
|
2008-09-22 |
2012-02-02 |
エルロン・セラピューティクス・インコーポレイテッド |
精製されたポリペプチド組成物を調製するための方法
|
|
AU2009294877C1
(en)
|
2008-09-22 |
2015-05-07 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
JP2012509902A
(ja)
|
2008-11-24 |
2012-04-26 |
エルロン・セラピューティクス・インコーポレイテッド |
改善された特性を有するペプチド模倣大環状分子
|
|
JP2012515172A
(ja)
|
2009-01-14 |
2012-07-05 |
エルロン・セラピューティクス・インコーポレイテッド |
ペプチド模倣大環状分子
|
|
SI2393828T1
(sl)
|
2009-02-03 |
2017-01-31 |
Amunix Operating Inc. |
Podaljšani rekombinantni polipetidi in sestavki, ki jih obsegajo
|
|
WO2010096052A1
(en)
|
2009-02-19 |
2010-08-26 |
Merck Sharp & Dohme Corp. |
Oxyntomodulin analogs
|
|
KR20120092611A
(ko)
*
|
2009-09-30 |
2012-08-21 |
글락소 그룹 리미티드 |
연장된 반감기를 갖는 약물 융합체 및 컨쥬게이트
|
|
US20110223149A1
(en)
|
2009-10-14 |
2011-09-15 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
CN104327182B
(zh)
|
2009-12-16 |
2020-04-17 |
诺沃—诺迪斯克有限公司 |
双酰化glp-1衍生物
|
|
US20110243943A1
(en)
|
2010-04-02 |
2011-10-06 |
Athena Discovery, Inc. |
Treatment using relaxin-fusion proteins with extended in vivo half-lives
|
|
JP2013532172A
(ja)
*
|
2010-07-09 |
2013-08-15 |
ダナ ファーバー キャンサー インスティテュート インコーポレイテッド |
安定化したインスリン分泌促進ペプチド及び使用方法
|
|
CA2803188A1
(en)
|
2010-07-09 |
2012-01-12 |
Antonello Pessi |
Lipid-conjugated antibodies
|
|
KR101382593B1
(ko)
*
|
2010-07-21 |
2014-04-10 |
한미사이언스 주식회사 |
신규한 지속형 글루카곤 결합체 및 이를 포함하는 비만 예방 및 치료용 약학적 조성물
|
|
EP3572091B1
(en)
|
2010-08-17 |
2023-12-13 |
Ambrx, Inc. |
Modified relaxin polypeptides and their uses
|
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
|
US9029332B2
(en)
|
2010-12-15 |
2015-05-12 |
The Research Foundation For The State University Of New York |
Cross-linked peptides and proteins, methods of making same, and uses thereof
|
|
SG191252A1
(en)
|
2010-12-22 |
2013-07-31 |
Marcadia Biotech Inc |
Methods for treating metabolic disorders and obesity with gip and glp-1 receptor-active glucagon-based peptides
|
|
CA2821766A1
(en)
|
2010-12-22 |
2012-06-28 |
Indiana University Research And Technology Corporation |
Glucagon analogs exhibiting gip receptor activity
|
|
CA2834657A1
(en)
*
|
2011-04-29 |
2012-11-01 |
Kinemed, Inc. |
Chemical modification of apolipoprotein mimetic peptides for the production of therapeutic agents
|
|
RU2014103288A
(ru)
|
2011-07-01 |
2015-08-10 |
Байер Интеллектчуал Проперти Гмбх |
Слитые полипептиды релаксина и их применение
|
|
KR20140039257A
(ko)
|
2011-07-08 |
2014-04-01 |
바이엘 인텔렉쳐 프로퍼티 게엠베하 |
릴랙신을 방출하는 융합 단백질 및 이의 용도
|
|
CN104039342A
(zh)
|
2011-10-18 |
2014-09-10 |
爱勒让治疗公司 |
拟肽大环化合物
|
|
KR101895047B1
(ko)
*
|
2011-12-30 |
2018-09-06 |
한미사이언스 주식회사 |
면역글로불린 단편을 이용한 위치 특이적 글루카곤 유사 펩타이드-2 약물 결합체
|
|
HK1205454A1
(en)
|
2012-02-15 |
2015-12-18 |
Aileron Therapeutics, Inc. |
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
|
|
CN104302408B
(zh)
|
2012-02-27 |
2016-12-14 |
阿穆尼克斯运营公司 |
Xten缀合组合物和制造其的方法
|
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
|
TW201402611A
(zh)
|
2012-06-21 |
2014-01-16 |
Univ Indiana Res & Tech Corp |
具有改變之ｆｃ效應子功能之腸促胰島素受體配體多肽ｆｃ區融合多肽及結合物
|
|
US9273093B2
(en)
|
2012-10-11 |
2016-03-01 |
Protagonist Therapeutics, Inc. |
α4β7 peptide dimer antagonists
|
|
SG11201503052RA
(en)
|
2012-11-01 |
2015-05-28 |
Aileron Therapeutics Inc |
Disubstituted amino acids and methods of preparation and use thereof
|
|
US10286078B2
(en)
|
2013-09-13 |
2019-05-14 |
The California Institute For Biomedical Research |
Modified therapeutic agents and compositions thereof
|
|
CA2933701C
(en)
|
2013-12-18 |
2022-05-31 |
The California Institute For Biomedical Research |
Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereof
|
|
WO2015095684A1
(en)
|
2013-12-20 |
2015-06-25 |
Indiana University Research And Technology Corporation |
Lipidated incretin receptor ligand human immunoglobulin fc-region fusion polypeptides
|
|
US20180228907A1
(en)
|
2014-04-14 |
2018-08-16 |
Arvinas, Inc. |
Cereblon ligands and bifunctional compounds comprising the same
|
|
JOP20200119A1
(ar)
|
2015-01-09 |
2017-06-16 |
Lilly Co Eli |
مركبات مساعد مشترك من gip وglp-1
|
|
MA41794A
(fr)
|
2015-03-18 |
2018-01-23 |
The California Institute For Biomedical Res |
Agents thérapeutiques modifiés et compositions associées
|
|
WO2016205488A1
(en)
|
2015-06-17 |
2016-12-22 |
The California Institute For Biomedical Research |
Modified therapeutic agents and compositions thereof
|
|
WO2017007612A1
(en)
|
2015-07-07 |
2017-01-12 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
WO2017024317A2
(en)
|
2015-08-06 |
2017-02-09 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
CA2994969A1
(en)
|
2015-08-06 |
2017-02-09 |
Dana-Farber Cancer Institute, Inc. |
Targeted protein degradation to attenuate adoptive t-cell therapy associated adverse inflammatory responses
|
|
US9809603B1
(en)
|
2015-08-18 |
2017-11-07 |
Deuterx, Llc |
Deuterium-enriched isoindolinonyl-piperidinonyl conjugates and oxoquinazolin-3(4H)-yl-piperidinonyl conjugates and methods of treating medical disorders using same
|
|
WO2017210600A1
(en)
|
2016-06-03 |
2017-12-07 |
The Scripps Research Institute |
Compositions and methods of modulating immune response
|
|
KR102839545B1
(ko)
|
2016-12-23 |
2025-07-29 |
아비나스 오퍼레이션스, 인코포레이티드 |
급속 진행성 섬유육종 폴리펩티드의 표적화 분해를 위한 화합물 및 방법
|
|
EP3580212A4
(en)
|
2017-02-08 |
2021-03-17 |
Dana Farber Cancer Institute, Inc. |
REGULATION OF CHEMERIC ANTIGEN RECEPTORS
|
|
CN110621322A
(zh)
|
2017-02-08 |
2019-12-27 |
达纳-法伯癌症研究所有限公司 |
用异双功能性化合物进行的可调节的内源性蛋白质降解
|
|
KR20240033100A
(ko)
|
2017-04-05 |
2024-03-12 |
레볼루션 메디슨즈, 인크. |
협동 결합에 참여하는 화합물 및 그의 용도
|
|
CN112020358A
(zh)
|
2018-02-23 |
2020-12-01 |
达纳-法伯癌症研究所有限公司 |
诱导蛋白质选择性降解的小分子及其用途
|
|
WO2020023386A1
(en)
|
2018-07-23 |
2020-01-30 |
Eli Lilly And Company |
Gip/glp1 co-agonist compounds
|
|
EP3864030A4
(en)
|
2018-10-12 |
2022-09-21 |
The Scripps Research Institute |
Compounds and methods for dcaf-mediated protein degradation
|
|
CA3136163A1
(en)
|
2019-04-11 |
2020-10-15 |
Jiangsu Hansoh Pharmaceutical Group Co., Ltd. |
Multi-receptor agonist and medical use thereof
|
|
CN113383014B
(zh)
|
2019-11-15 |
2024-06-18 |
江苏豪森药业集团有限公司 |
双受体重激动剂化合物及其药物组合物
|
|
CA3163522A1
(en)
|
2019-12-04 |
2021-06-10 |
The Scripps Research Institute |
Glp2 receptor agonists and methods of use
|
|
CN117794946A
(zh)
|
2021-06-09 |
2024-03-29 |
斯克利普斯研究所 |
长效双重gip/glp-1肽缀合物及使用方法
|